v3.25.1
Schedule of Company’s Segments Including a Reconciliation to Income Before Taxes (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]      
Intersegment revenues $ 1,641,685 $ 1,576,286  
Total revenue 1,641,685 1,576,286  
Elimination of intersegment revenue 1,637,185 1,576,286  
Total consolidated revenue 1,637,185 1,576,286  
Cost of revenue 1,064,227 862,105  
Sales and marketing 12,974 7,609  
General and administrative 1,307,684 272,081  
Research and development 265,663  
Impairment loss 14,645,069    
Depreciation and amortization 214,887 214,813  
Segment profit (loss) (15,873,319) 219,679  
Other income (loss) 15,096 94,655  
Interest expense (311,270) (181,295)  
Other corporate expenses (1,229,593) (1,727,716)  
Loss before taxes (17,399,086) (1,594,677)  
Assets 31,744,110   $ 46,449,182
Revenue From External Customers [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 1,637,185 1,576,286  
Total revenue 1,637,185 1,576,286  
Inter Segment Revenue [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 4,500  
Total revenue 4,500  
Fertility Clinic Services [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 1,621,553 1,537,199  
Total revenue 1,621,553 1,537,199  
Cost of revenue 1,060,243 865,104  
Sales and marketing 12,974 7,609  
General and administrative 307,101 272,081  
Research and development  
Impairment loss    
Depreciation and amortization 212,456 212,382  
Segment profit (loss) 28,778 180,024  
Assets 10,654,643 11,471,948  
Fertility Clinic Services [Member] | Revenue From External Customers [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 1,621,553 1,537,199  
Total revenue 1,621,553 1,537,199  
Fertility Clinic Services [Member] | Inter Segment Revenue [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues  
Total revenue  
Invocell Device [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 20,132 39,087  
Total revenue 20,132 39,087  
Cost of revenue 3,984 (2,999)  
Sales and marketing  
General and administrative  
Research and development  
Impairment loss    
Depreciation and amortization 2,431 2,431  
Segment profit (loss) 13,717 39,655  
Assets 39,534 49,259  
Invocell Device [Member] | Revenue From External Customers [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 15,632 39,087  
Total revenue 15,632 39,087  
Invocell Device [Member] | Inter Segment Revenue [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues 4,500  
Total revenue 4,500  
Therapeutics [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues  
Total revenue  
Cost of revenue  
Sales and marketing  
General and administrative 1,000,583  
Research and development 265,663  
Impairment loss 14,645,069    
Depreciation and amortization  
Segment profit (loss) (15,911,315)  
Assets 16,942,932  
Therapeutics [Member] | Revenue From External Customers [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues  
Total revenue  
Therapeutics [Member] | Inter Segment Revenue [Member]      
Segment Reporting Information [Line Items]      
Intersegment revenues  
Total revenue  
Other Operating Segment [Member]      
Segment Reporting Information [Line Items]      
Elimination of intersegment revenue (4,500)  
Total consolidated revenue $ (4,500)